Frazier Life Sciences Management

Frazier Life Sciences Management as of June 30, 2023

Portfolio Holdings for Frazier Life Sciences Management

Frazier Life Sciences Management holds 48 positions in its portfolio as reported in the June 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Hillevax (HLVX) 10.0 $168M 9.8M 17.19
Chinook Therapeutics 10.0 $167M 4.3M 38.42
Phathom Pharmaceuticals (PHAT) 8.6 $145M 10M 14.32
Newamsterdam Pharma Company Ordinary Shares (NAMS) 7.7 $129M 11M 11.89
Krystal Biotech (KRYS) 6.9 $116M 990k 117.40
Mirum Pharmaceuticals (MIRM) 6.7 $113M 4.4M 25.87
Arcutis Biotherapeutics (ARQT) 4.9 $83M 8.7M 9.53
Syndax Pharmaceuticals (SNDX) 4.6 $78M 3.7M 20.93
Verona Pharma Sponsored Ads (VRNA) 3.7 $62M 2.9M 21.14
Vaxcyte (PCVX) 3.5 $58M 1.2M 49.94
Rhythm Pharmaceuticals (RYTM) 2.1 $36M 2.2M 16.49
Bridgebio Pharma (BBIO) 2.0 $34M 2.0M 17.20
Tarsus Pharmaceuticals (TARS) 1.9 $32M 1.8M 18.07
Alpine Immune Sciences (ALPN) 1.8 $31M 3.0M 10.28
Kalvista Pharmaceuticals (KALV) 1.7 $29M 3.2M 9.00
Disc Medicine (IRON) 1.7 $29M 655k 44.40
Crinetics Pharmaceuticals In (CRNX) 1.5 $26M 1.4M 18.02
Revolution Medicines (RVMD) 1.4 $23M 855k 26.75
Theseus Pharmaceuticals 1.3 $21M 2.2M 9.33
ACADIA Pharmaceuticals (ACAD) 1.2 $21M 857k 23.95
Merus N V (MRUS) 1.2 $20M 747k 26.33
Anaptysbio Inc Common (ANAB) 1.1 $18M 900k 20.34
Cogent Biosciences (COGT) 1.1 $18M 1.5M 11.84
Tyra Biosciences (TYRA) 1.0 $18M 1.0M 17.03
Aerovate Therapeutics (AVTE) 1.0 $17M 995k 17.15
Enliven Therapeutics (ELVN) 1.0 $17M 831k 20.41
Oric Pharmaceuticals (ORIC) 1.0 $17M 2.1M 7.76
Trevi Therapeutics (TRVI) 1.0 $16M 6.9M 2.39
Morphic Hldg (MORF) 0.9 $15M 266k 57.33
Cerevel Therapeutics Hldng I (CERE) 0.7 $13M 393k 31.79
Reata Pharmaceuticals Cl A 0.6 $10M 100k 101.96
Macrogenics (MGNX) 0.6 $9.6M 1.8M 5.35
Replimune Group (REPL) 0.5 $9.0M 387k 23.22
Autolus Therapeutics Spon Ads (AUTL) 0.5 $8.9M 3.7M 2.38
Prothena Corp SHS (PRTA) 0.5 $8.7M 128k 68.28
Intellia Therapeutics (NTLA) 0.5 $8.3M 204k 40.78
Arvinas Ord (ARVN) 0.4 $7.1M 285k 24.82
Edgewise Therapeutics (EWTX) 0.3 $5.8M 749k 7.75
Immunovant (IMVT) 0.3 $5.7M 300k 18.97
Bluebird Bio (BLUE) 0.3 $5.6M 1.7M 3.29
Deciphera Pharmaceuticals (DCPH) 0.3 $5.2M 370k 14.08
Silence Therapeutics Ads (SLN) 0.3 $4.8M 881k 5.50
Gritstone Oncology Ord (GRTS) 0.3 $4.7M 2.4M 1.95
Sutro Biopharma (STRO) 0.2 $3.6M 780k 4.65
Adc Therapeutics Sa SHS (ADCT) 0.2 $3.5M 1.6M 2.15
Aclaris Therapeutics (ACRS) 0.2 $2.7M 264k 10.37
Passage Bio (PASG) 0.1 $1.7M 1.9M 0.94
Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) 0.1 $1.0M 500k 2.09